ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Anti-GFP Antibody Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-0E16937
Home | Market Reports | Science| Biological Sciences
Global Anti GFP Antibody Market Research Report 2024
BUY CHAPTERS

Global Anti-GFP Antibody Market Research Report 2025

Code: QYRE-Auto-0E16937
Report
September 2025
Pages:118
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
FUJIFILM Wako Chemicals
ProSci
GeneTex
Bioss
Rockland Immunochemicals
Cell Signaling Technology
Novus Biologicals
Thermo Fisher Scientific
Biorbyt
R&D Systems
BioLegend
Origene Technologies
ImmuQuest
Abbexa
Epigentek
Synaptic Systems
Santa Cruz Biotechnology
Proteintech Group
IBL
LSBio
Signalway Antibody
Agrisera
Bio X Cell
StressMarq Biosciences
RayBiotech
Abnova

Anti-GFP Antibody Market

The global market for Anti-GFP Antibody was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Anti-GFP Antibody refers to an antibody that specifically recognizes and binds to green fluorescent protein (GFP). GFP is a naturally occurring protein that emits green fluorescence when exposed to light in the blue to UV range. It is widely used as a reporter molecule in molecular biology and cell biology research to visualize protein expression and localization in vivo. The Anti-GFP Antibody is used to detect and quantify GFP-tagged proteins in various experimental settings, including western blotting, immunofluorescence, and immunohistochemistry.
The industry trend for Anti-GFP Antibody has experienced significant growth due to the increasing use of GFP in genetic engineering, cell tracking, and fluorescence microscopy. The antibody is essential for researchers to validate the successful expression and functionality of GFP-tagged fusion proteins in their experimental systems. Furthermore, the development of more sensitive and specific Anti-GFP Antibodies, as well as the expansion of applications such as live-cell imaging and protein-protein interaction studies, is driving the demand for this product. As the field of fluorescent protein technology continues to advance, the industry trend for Anti-GFP Antibody is expected to remain strong.
This report aims to provide a comprehensive presentation of the global market for Anti-GFP Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-GFP Antibody.
The Anti-GFP Antibody market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anti-GFP Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-GFP Antibody companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Anti-GFP Antibody Market Report

Report Metric Details
Report Name Anti-GFP Antibody Market
Segment by Type
  • Monoclonal Antibody
  • Polyclonal Antibody
Segment by Application
  • Biotechnology
  • Medical
  • University
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company FUJIFILM Wako Chemicals, ProSci, GeneTex, Bioss, Rockland Immunochemicals, Cell Signaling Technology, Novus Biologicals, Thermo Fisher Scientific, Biorbyt, R&D Systems, BioLegend, OriGene Technologies, ImmuQuest, Abbexa, EpiGentek, Synaptic Systems, Santa Cruz Biotechnology, Proteintech Group, IBL, LSBio, Signalway Antibody, Agrisera, Bio X Cell, StressMarq Biosciences, RayBiotech, Abnova
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Anti-GFP Antibody company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Anti-GFP Antibody Market report?

Ans: The main players in the Anti-GFP Antibody Market are FUJIFILM Wako Chemicals, ProSci, GeneTex, Bioss, Rockland Immunochemicals, Cell Signaling Technology, Novus Biologicals, Thermo Fisher Scientific, Biorbyt, R&D Systems, BioLegend, OriGene Technologies, ImmuQuest, Abbexa, EpiGentek, Synaptic Systems, Santa Cruz Biotechnology, Proteintech Group, IBL, LSBio, Signalway Antibody, Agrisera, Bio X Cell, StressMarq Biosciences, RayBiotech, Abnova

What are the Application segmentation covered in the Anti-GFP Antibody Market report?

Ans: The Applications covered in the Anti-GFP Antibody Market report are Biotechnology, Medical, University, Others

What are the Type segmentation covered in the Anti-GFP Antibody Market report?

Ans: The Types covered in the Anti-GFP Antibody Market report are Monoclonal Antibody, Polyclonal Antibody

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-GFP Antibody Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Monoclonal Antibody
1.2.3 Polyclonal Antibody
1.3 Market by Application
1.3.1 Global Anti-GFP Antibody Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biotechnology
1.3.3 Medical
1.3.4 University
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-GFP Antibody Market Perspective (2020-2031)
2.2 Global Anti-GFP Antibody Growth Trends by Region
2.2.1 Global Anti-GFP Antibody Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Anti-GFP Antibody Historic Market Size by Region (2020-2025)
2.2.3 Anti-GFP Antibody Forecasted Market Size by Region (2026-2031)
2.3 Anti-GFP Antibody Market Dynamics
2.3.1 Anti-GFP Antibody Industry Trends
2.3.2 Anti-GFP Antibody Market Drivers
2.3.3 Anti-GFP Antibody Market Challenges
2.3.4 Anti-GFP Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-GFP Antibody Players by Revenue
3.1.1 Global Top Anti-GFP Antibody Players by Revenue (2020-2025)
3.1.2 Global Anti-GFP Antibody Revenue Market Share by Players (2020-2025)
3.2 Global Anti-GFP Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Anti-GFP Antibody Revenue
3.4 Global Anti-GFP Antibody Market Concentration Ratio
3.4.1 Global Anti-GFP Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-GFP Antibody Revenue in 2024
3.5 Global Key Players of Anti-GFP Antibody Head office and Area Served
3.6 Global Key Players of Anti-GFP Antibody, Product and Application
3.7 Global Key Players of Anti-GFP Antibody, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-GFP Antibody Breakdown Data by Type
4.1 Global Anti-GFP Antibody Historic Market Size by Type (2020-2025)
4.2 Global Anti-GFP Antibody Forecasted Market Size by Type (2026-2031)
5 Anti-GFP Antibody Breakdown Data by Application
5.1 Global Anti-GFP Antibody Historic Market Size by Application (2020-2025)
5.2 Global Anti-GFP Antibody Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Anti-GFP Antibody Market Size (2020-2031)
6.2 North America Anti-GFP Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Anti-GFP Antibody Market Size by Country (2020-2025)
6.4 North America Anti-GFP Antibody Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anti-GFP Antibody Market Size (2020-2031)
7.2 Europe Anti-GFP Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Anti-GFP Antibody Market Size by Country (2020-2025)
7.4 Europe Anti-GFP Antibody Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti-GFP Antibody Market Size (2020-2031)
8.2 Asia-Pacific Anti-GFP Antibody Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Anti-GFP Antibody Market Size by Region (2020-2025)
8.4 Asia-Pacific Anti-GFP Antibody Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anti-GFP Antibody Market Size (2020-2031)
9.2 Latin America Anti-GFP Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Anti-GFP Antibody Market Size by Country (2020-2025)
9.4 Latin America Anti-GFP Antibody Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-GFP Antibody Market Size (2020-2031)
10.2 Middle East & Africa Anti-GFP Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Anti-GFP Antibody Market Size by Country (2020-2025)
10.4 Middle East & Africa Anti-GFP Antibody Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 FUJIFILM Wako Chemicals
11.1.1 FUJIFILM Wako Chemicals Company Details
11.1.2 FUJIFILM Wako Chemicals Business Overview
11.1.3 FUJIFILM Wako Chemicals Anti-GFP Antibody Introduction
11.1.4 FUJIFILM Wako Chemicals Revenue in Anti-GFP Antibody Business (2020-2025)
11.1.5 FUJIFILM Wako Chemicals Recent Development
11.2 ProSci
11.2.1 ProSci Company Details
11.2.2 ProSci Business Overview
11.2.3 ProSci Anti-GFP Antibody Introduction
11.2.4 ProSci Revenue in Anti-GFP Antibody Business (2020-2025)
11.2.5 ProSci Recent Development
11.3 GeneTex
11.3.1 GeneTex Company Details
11.3.2 GeneTex Business Overview
11.3.3 GeneTex Anti-GFP Antibody Introduction
11.3.4 GeneTex Revenue in Anti-GFP Antibody Business (2020-2025)
11.3.5 GeneTex Recent Development
11.4 Bioss
11.4.1 Bioss Company Details
11.4.2 Bioss Business Overview
11.4.3 Bioss Anti-GFP Antibody Introduction
11.4.4 Bioss Revenue in Anti-GFP Antibody Business (2020-2025)
11.4.5 Bioss Recent Development
11.5 Rockland Immunochemicals
11.5.1 Rockland Immunochemicals Company Details
11.5.2 Rockland Immunochemicals Business Overview
11.5.3 Rockland Immunochemicals Anti-GFP Antibody Introduction
11.5.4 Rockland Immunochemicals Revenue in Anti-GFP Antibody Business (2020-2025)
11.5.5 Rockland Immunochemicals Recent Development
11.6 Cell Signaling Technology
11.6.1 Cell Signaling Technology Company Details
11.6.2 Cell Signaling Technology Business Overview
11.6.3 Cell Signaling Technology Anti-GFP Antibody Introduction
11.6.4 Cell Signaling Technology Revenue in Anti-GFP Antibody Business (2020-2025)
11.6.5 Cell Signaling Technology Recent Development
11.7 Novus Biologicals
11.7.1 Novus Biologicals Company Details
11.7.2 Novus Biologicals Business Overview
11.7.3 Novus Biologicals Anti-GFP Antibody Introduction
11.7.4 Novus Biologicals Revenue in Anti-GFP Antibody Business (2020-2025)
11.7.5 Novus Biologicals Recent Development
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Details
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific Anti-GFP Antibody Introduction
11.8.4 Thermo Fisher Scientific Revenue in Anti-GFP Antibody Business (2020-2025)
11.8.5 Thermo Fisher Scientific Recent Development
11.9 Biorbyt
11.9.1 Biorbyt Company Details
11.9.2 Biorbyt Business Overview
11.9.3 Biorbyt Anti-GFP Antibody Introduction
11.9.4 Biorbyt Revenue in Anti-GFP Antibody Business (2020-2025)
11.9.5 Biorbyt Recent Development
11.10 R&D Systems
11.10.1 R&D Systems Company Details
11.10.2 R&D Systems Business Overview
11.10.3 R&D Systems Anti-GFP Antibody Introduction
11.10.4 R&D Systems Revenue in Anti-GFP Antibody Business (2020-2025)
11.10.5 R&D Systems Recent Development
11.11 BioLegend
11.11.1 BioLegend Company Details
11.11.2 BioLegend Business Overview
11.11.3 BioLegend Anti-GFP Antibody Introduction
11.11.4 BioLegend Revenue in Anti-GFP Antibody Business (2020-2025)
11.11.5 BioLegend Recent Development
11.12 OriGene Technologies
11.12.1 OriGene Technologies Company Details
11.12.2 OriGene Technologies Business Overview
11.12.3 OriGene Technologies Anti-GFP Antibody Introduction
11.12.4 OriGene Technologies Revenue in Anti-GFP Antibody Business (2020-2025)
11.12.5 OriGene Technologies Recent Development
11.13 ImmuQuest
11.13.1 ImmuQuest Company Details
11.13.2 ImmuQuest Business Overview
11.13.3 ImmuQuest Anti-GFP Antibody Introduction
11.13.4 ImmuQuest Revenue in Anti-GFP Antibody Business (2020-2025)
11.13.5 ImmuQuest Recent Development
11.14 Abbexa
11.14.1 Abbexa Company Details
11.14.2 Abbexa Business Overview
11.14.3 Abbexa Anti-GFP Antibody Introduction
11.14.4 Abbexa Revenue in Anti-GFP Antibody Business (2020-2025)
11.14.5 Abbexa Recent Development
11.15 EpiGentek
11.15.1 EpiGentek Company Details
11.15.2 EpiGentek Business Overview
11.15.3 EpiGentek Anti-GFP Antibody Introduction
11.15.4 EpiGentek Revenue in Anti-GFP Antibody Business (2020-2025)
11.15.5 EpiGentek Recent Development
11.16 Synaptic Systems
11.16.1 Synaptic Systems Company Details
11.16.2 Synaptic Systems Business Overview
11.16.3 Synaptic Systems Anti-GFP Antibody Introduction
11.16.4 Synaptic Systems Revenue in Anti-GFP Antibody Business (2020-2025)
11.16.5 Synaptic Systems Recent Development
11.17 Santa Cruz Biotechnology
11.17.1 Santa Cruz Biotechnology Company Details
11.17.2 Santa Cruz Biotechnology Business Overview
11.17.3 Santa Cruz Biotechnology Anti-GFP Antibody Introduction
11.17.4 Santa Cruz Biotechnology Revenue in Anti-GFP Antibody Business (2020-2025)
11.17.5 Santa Cruz Biotechnology Recent Development
11.18 Proteintech Group
11.18.1 Proteintech Group Company Details
11.18.2 Proteintech Group Business Overview
11.18.3 Proteintech Group Anti-GFP Antibody Introduction
11.18.4 Proteintech Group Revenue in Anti-GFP Antibody Business (2020-2025)
11.18.5 Proteintech Group Recent Development
11.19 IBL
11.19.1 IBL Company Details
11.19.2 IBL Business Overview
11.19.3 IBL Anti-GFP Antibody Introduction
11.19.4 IBL Revenue in Anti-GFP Antibody Business (2020-2025)
11.19.5 IBL Recent Development
11.20 LSBio
11.20.1 LSBio Company Details
11.20.2 LSBio Business Overview
11.20.3 LSBio Anti-GFP Antibody Introduction
11.20.4 LSBio Revenue in Anti-GFP Antibody Business (2020-2025)
11.20.5 LSBio Recent Development
11.21 Signalway Antibody
11.21.1 Signalway Antibody Company Details
11.21.2 Signalway Antibody Business Overview
11.21.3 Signalway Antibody Anti-GFP Antibody Introduction
11.21.4 Signalway Antibody Revenue in Anti-GFP Antibody Business (2020-2025)
11.21.5 Signalway Antibody Recent Development
11.22 Agrisera
11.22.1 Agrisera Company Details
11.22.2 Agrisera Business Overview
11.22.3 Agrisera Anti-GFP Antibody Introduction
11.22.4 Agrisera Revenue in Anti-GFP Antibody Business (2020-2025)
11.22.5 Agrisera Recent Development
11.23 Bio X Cell
11.23.1 Bio X Cell Company Details
11.23.2 Bio X Cell Business Overview
11.23.3 Bio X Cell Anti-GFP Antibody Introduction
11.23.4 Bio X Cell Revenue in Anti-GFP Antibody Business (2020-2025)
11.23.5 Bio X Cell Recent Development
11.24 StressMarq Biosciences
11.24.1 StressMarq Biosciences Company Details
11.24.2 StressMarq Biosciences Business Overview
11.24.3 StressMarq Biosciences Anti-GFP Antibody Introduction
11.24.4 StressMarq Biosciences Revenue in Anti-GFP Antibody Business (2020-2025)
11.24.5 StressMarq Biosciences Recent Development
11.25 RayBiotech
11.25.1 RayBiotech Company Details
11.25.2 RayBiotech Business Overview
11.25.3 RayBiotech Anti-GFP Antibody Introduction
11.25.4 RayBiotech Revenue in Anti-GFP Antibody Business (2020-2025)
11.25.5 RayBiotech Recent Development
11.26 Abnova
11.26.1 Abnova Company Details
11.26.2 Abnova Business Overview
11.26.3 Abnova Anti-GFP Antibody Introduction
11.26.4 Abnova Revenue in Anti-GFP Antibody Business (2020-2025)
11.26.5 Abnova Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
FUJIFILM Wako Chemicals
ProSci
GeneTex
Bioss
Rockland Immunochemicals
Cell Signaling Technology
Novus Biologicals
Thermo Fisher Scientific
Biorbyt
R&D Systems
BioLegend
Origene Technologies
ImmuQuest
Abbexa
Epigentek
Synaptic Systems
Santa Cruz Biotechnology
Proteintech Group
IBL
LSBio
Signalway Antibody
Agrisera
Bio X Cell
StressMarq Biosciences
RayBiotech
Abnova
List of Tables
 Table 1. Global Anti-GFP Antibody Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Monoclonal Antibody
 Table 3. Key Players of Polyclonal Antibody
 Table 4. Global Anti-GFP Antibody Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Anti-GFP Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Anti-GFP Antibody Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Anti-GFP Antibody Market Share by Region (2020-2025)
 Table 8. Global Anti-GFP Antibody Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Anti-GFP Antibody Market Share by Region (2026-2031)
 Table 10. Anti-GFP Antibody Market Trends
 Table 11. Anti-GFP Antibody Market Drivers
 Table 12. Anti-GFP Antibody Market Challenges
 Table 13. Anti-GFP Antibody Market Restraints
 Table 14. Global Anti-GFP Antibody Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Anti-GFP Antibody Market Share by Players (2020-2025)
 Table 16. Global Top Anti-GFP Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-GFP Antibody as of 2024)
 Table 17. Ranking of Global Top Anti-GFP Antibody Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Anti-GFP Antibody Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Anti-GFP Antibody, Headquarters and Area Served
 Table 20. Global Key Players of Anti-GFP Antibody, Product and Application
 Table 21. Global Key Players of Anti-GFP Antibody, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Anti-GFP Antibody Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Anti-GFP Antibody Revenue Market Share by Type (2020-2025)
 Table 25. Global Anti-GFP Antibody Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Anti-GFP Antibody Revenue Market Share by Type (2026-2031)
 Table 27. Global Anti-GFP Antibody Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Anti-GFP Antibody Revenue Market Share by Application (2020-2025)
 Table 29. Global Anti-GFP Antibody Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Anti-GFP Antibody Revenue Market Share by Application (2026-2031)
 Table 31. North America Anti-GFP Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Anti-GFP Antibody Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Anti-GFP Antibody Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Anti-GFP Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Anti-GFP Antibody Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Anti-GFP Antibody Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Anti-GFP Antibody Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Anti-GFP Antibody Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Anti-GFP Antibody Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Anti-GFP Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Anti-GFP Antibody Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Anti-GFP Antibody Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Anti-GFP Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Anti-GFP Antibody Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Anti-GFP Antibody Market Size by Country (2026-2031) & (US$ Million)
 Table 46. FUJIFILM Wako Chemicals Company Details
 Table 47. FUJIFILM Wako Chemicals Business Overview
 Table 48. FUJIFILM Wako Chemicals Anti-GFP Antibody Product
 Table 49. FUJIFILM Wako Chemicals Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
 Table 50. FUJIFILM Wako Chemicals Recent Development
 Table 51. ProSci Company Details
 Table 52. ProSci Business Overview
 Table 53. ProSci Anti-GFP Antibody Product
 Table 54. ProSci Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
 Table 55. ProSci Recent Development
 Table 56. GeneTex Company Details
 Table 57. GeneTex Business Overview
 Table 58. GeneTex Anti-GFP Antibody Product
 Table 59. GeneTex Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
 Table 60. GeneTex Recent Development
 Table 61. Bioss Company Details
 Table 62. Bioss Business Overview
 Table 63. Bioss Anti-GFP Antibody Product
 Table 64. Bioss Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
 Table 65. Bioss Recent Development
 Table 66. Rockland Immunochemicals Company Details
 Table 67. Rockland Immunochemicals Business Overview
 Table 68. Rockland Immunochemicals Anti-GFP Antibody Product
 Table 69. Rockland Immunochemicals Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
 Table 70. Rockland Immunochemicals Recent Development
 Table 71. Cell Signaling Technology Company Details
 Table 72. Cell Signaling Technology Business Overview
 Table 73. Cell Signaling Technology Anti-GFP Antibody Product
 Table 74. Cell Signaling Technology Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
 Table 75. Cell Signaling Technology Recent Development
 Table 76. Novus Biologicals Company Details
 Table 77. Novus Biologicals Business Overview
 Table 78. Novus Biologicals Anti-GFP Antibody Product
 Table 79. Novus Biologicals Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
 Table 80. Novus Biologicals Recent Development
 Table 81. Thermo Fisher Scientific Company Details
 Table 82. Thermo Fisher Scientific Business Overview
 Table 83. Thermo Fisher Scientific Anti-GFP Antibody Product
 Table 84. Thermo Fisher Scientific Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
 Table 85. Thermo Fisher Scientific Recent Development
 Table 86. Biorbyt Company Details
 Table 87. Biorbyt Business Overview
 Table 88. Biorbyt Anti-GFP Antibody Product
 Table 89. Biorbyt Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
 Table 90. Biorbyt Recent Development
 Table 91. R&D Systems Company Details
 Table 92. R&D Systems Business Overview
 Table 93. R&D Systems Anti-GFP Antibody Product
 Table 94. R&D Systems Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
 Table 95. R&D Systems Recent Development
 Table 96. BioLegend Company Details
 Table 97. BioLegend Business Overview
 Table 98. BioLegend Anti-GFP Antibody Product
 Table 99. BioLegend Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
 Table 100. BioLegend Recent Development
 Table 101. OriGene Technologies Company Details
 Table 102. OriGene Technologies Business Overview
 Table 103. OriGene Technologies Anti-GFP Antibody Product
 Table 104. OriGene Technologies Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
 Table 105. OriGene Technologies Recent Development
 Table 106. ImmuQuest Company Details
 Table 107. ImmuQuest Business Overview
 Table 108. ImmuQuest Anti-GFP Antibody Product
 Table 109. ImmuQuest Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
 Table 110. ImmuQuest Recent Development
 Table 111. Abbexa Company Details
 Table 112. Abbexa Business Overview
 Table 113. Abbexa Anti-GFP Antibody Product
 Table 114. Abbexa Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
 Table 115. Abbexa Recent Development
 Table 116. EpiGentek Company Details
 Table 117. EpiGentek Business Overview
 Table 118. EpiGentek Anti-GFP Antibody Product
 Table 119. EpiGentek Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
 Table 120. EpiGentek Recent Development
 Table 121. Synaptic Systems Company Details
 Table 122. Synaptic Systems Business Overview
 Table 123. Synaptic Systems Anti-GFP Antibody Product
 Table 124. Synaptic Systems Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
 Table 125. Synaptic Systems Recent Development
 Table 126. Santa Cruz Biotechnology Company Details
 Table 127. Santa Cruz Biotechnology Business Overview
 Table 128. Santa Cruz Biotechnology Anti-GFP Antibody Product
 Table 129. Santa Cruz Biotechnology Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
 Table 130. Santa Cruz Biotechnology Recent Development
 Table 131. Proteintech Group Company Details
 Table 132. Proteintech Group Business Overview
 Table 133. Proteintech Group Anti-GFP Antibody Product
 Table 134. Proteintech Group Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
 Table 135. Proteintech Group Recent Development
 Table 136. IBL Company Details
 Table 137. IBL Business Overview
 Table 138. IBL Anti-GFP Antibody Product
 Table 139. IBL Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
 Table 140. IBL Recent Development
 Table 141. LSBio Company Details
 Table 142. LSBio Business Overview
 Table 143. LSBio Anti-GFP Antibody Product
 Table 144. LSBio Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
 Table 145. LSBio Recent Development
 Table 146. Signalway Antibody Company Details
 Table 147. Signalway Antibody Business Overview
 Table 148. Signalway Antibody Anti-GFP Antibody Product
 Table 149. Signalway Antibody Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
 Table 150. Signalway Antibody Recent Development
 Table 151. Agrisera Company Details
 Table 152. Agrisera Business Overview
 Table 153. Agrisera Anti-GFP Antibody Product
 Table 154. Agrisera Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
 Table 155. Agrisera Recent Development
 Table 156. Bio X Cell Company Details
 Table 157. Bio X Cell Business Overview
 Table 158. Bio X Cell Anti-GFP Antibody Product
 Table 159. Bio X Cell Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
 Table 160. Bio X Cell Recent Development
 Table 161. StressMarq Biosciences Company Details
 Table 162. StressMarq Biosciences Business Overview
 Table 163. StressMarq Biosciences Anti-GFP Antibody Product
 Table 164. StressMarq Biosciences Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
 Table 165. StressMarq Biosciences Recent Development
 Table 166. RayBiotech Company Details
 Table 167. RayBiotech Business Overview
 Table 168. RayBiotech Anti-GFP Antibody Product
 Table 169. RayBiotech Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
 Table 170. RayBiotech Recent Development
 Table 171. Abnova Company Details
 Table 172. Abnova Business Overview
 Table 173. Abnova Anti-GFP Antibody Product
 Table 174. Abnova Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
 Table 175. Abnova Recent Development
 Table 176. Research Programs/Design for This Report
 Table 177. Key Data Information from Secondary Sources
 Table 178. Key Data Information from Primary Sources
 Table 179. Authors List of This Report


List of Figures
 Figure 1. Anti-GFP Antibody Picture
 Figure 2. Global Anti-GFP Antibody Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Anti-GFP Antibody Market Share by Type: 2024 VS 2031
 Figure 4. Monoclonal Antibody Features
 Figure 5. Polyclonal Antibody Features
 Figure 6. Global Anti-GFP Antibody Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Anti-GFP Antibody Market Share by Application: 2024 VS 2031
 Figure 8. Biotechnology Case Studies
 Figure 9. Medical Case Studies
 Figure 10. University Case Studies
 Figure 11. Others Case Studies
 Figure 12. Anti-GFP Antibody Report Years Considered
 Figure 13. Global Anti-GFP Antibody Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Anti-GFP Antibody Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Anti-GFP Antibody Market Share by Region: 2024 VS 2031
 Figure 16. Global Anti-GFP Antibody Market Share by Players in 2024
 Figure 17. Global Top Anti-GFP Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-GFP Antibody as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Anti-GFP Antibody Revenue in 2024
 Figure 19. North America Anti-GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Anti-GFP Antibody Market Share by Country (2020-2031)
 Figure 21. United States Anti-GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Anti-GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Anti-GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Anti-GFP Antibody Market Share by Country (2020-2031)
 Figure 25. Germany Anti-GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Anti-GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Anti-GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Anti-GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Anti-GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Anti-GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Anti-GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Anti-GFP Antibody Market Share by Region (2020-2031)
 Figure 33. China Anti-GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Anti-GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Anti-GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Anti-GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Anti-GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Anti-GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Anti-GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Anti-GFP Antibody Market Share by Country (2020-2031)
 Figure 41. Mexico Anti-GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Anti-GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Anti-GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Anti-GFP Antibody Market Share by Country (2020-2031)
 Figure 45. Turkey Anti-GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Anti-GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Anti-GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. FUJIFILM Wako Chemicals Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
 Figure 49. ProSci Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
 Figure 50. GeneTex Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
 Figure 51. Bioss Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
 Figure 52. Rockland Immunochemicals Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
 Figure 53. Cell Signaling Technology Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
 Figure 54. Novus Biologicals Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
 Figure 55. Thermo Fisher Scientific Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
 Figure 56. Biorbyt Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
 Figure 57. R&D Systems Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
 Figure 58. BioLegend Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
 Figure 59. OriGene Technologies Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
 Figure 60. ImmuQuest Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
 Figure 61. Abbexa Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
 Figure 62. EpiGentek Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
 Figure 63. Synaptic Systems Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
 Figure 64. Santa Cruz Biotechnology Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
 Figure 65. Proteintech Group Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
 Figure 66. IBL Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
 Figure 67. LSBio Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
 Figure 68. Signalway Antibody Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
 Figure 69. Agrisera Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
 Figure 70. Bio X Cell Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
 Figure 71. StressMarq Biosciences Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
 Figure 72. RayBiotech Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
 Figure 73. Abnova Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
 Figure 74. Bottom-up and Top-down Approaches for This Report
 Figure 75. Data Triangulation
 Figure 76. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions